"Some of us clearly expect GSK not only being interested in the FIM technology applications but see this as the tip of the iceberg and a pharmaceutical application to be followed.
This would explain the many years GSK has been involved with us."
Agree 110% Surges. It's very fair to say that GSK haven't been collaborating with obj for 5 years now when obj only invented and presented the FIM technology less than two years ago...
I've attempted scouring GSK's current clinical trials for any clues but they've got hundreds in their pipeline. It's worth checking out some recent additions to their more recently revamped website if you haven't looked at it in the last couple of weeks
- Forums
- ASX - By Stock
- WFL
- obj groundhog day - tell me it isn't so!
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

obj groundhog day - tell me it isn't so!, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online